Stanley Skoryna
| Stanley Skoryna | |
|---|---|
| Born | Stanisław Constantine Skoryna September 4, 1920 Warsaw, Poland |
| 💀Died | July 6, 2003 (aged 82) Montreal, Quebec, CanadaJuly 6, 2003 (aged 82) |
| 🏳️ Citizenship | Canadian |
| 🎓 Alma mater | University of Vienna (MD) McGill University (MSc) |
| 💼 Occupation | |
| Known for | Leader of the Medical Expedition to Easter Island (METEI); indirect discovery of rapamycin |
Stanley Constantine Skoryna FACS (September 4, 1920 – July 6, 2003) was a Canadian physician and researcher, best known for being the leader of the Canadian Medical Expedition to Easter Island (METEI).
Early life and education
The son of a physician, Skoryna was born in Warsaw, attended high school in Czechoslovakia, and studied medicine and surgery at the University of Vienna in Austria, where he earned both an MD and a PhD.
During World War II, he served in the Medical Corps of the Polish Army under British Command. Following the war, he worked at the Post-Graduate Medical School in London, England, before emigrating to Canada in 1947 where he joined the faculty at McGill University in Montreal as a surgeon and researcher. He eventually rose to the rank of Professor of Surgery and served as the Director of the Gastro-Intestinal Research Laboratory at McGill for many years.[1]
Medical Expedition to Easter Island (METEI)
In collaboration with bacteriologist Georges Nógrády from the Université de Montréal, Skoryna organized and led the Medical Expedition to Easter Island (METEI). The expedition took place between November 1964 and February 1965 and consisted of 38 scientists.[2][3]
The primary goal of the mission was to study the health and genetics of the isolated Rapa Nui population before the construction of an international airport, which would end the island's isolation. Skoryna aimed to identify environmental and lifestyle factors linked to the development of cancer.
Discovery of Rapamycin
Although the expedition's primary research did not result in a definitive cancer breakthrough, it led to a major medical discovery. Georges Nógrády collected soil samples from across the island, which were later analyzed by Ayerst Pharmaceuticals. In 1972, researchers Claude Vézina and Surendra Sehgal isolated a compound produced by the bacterium Streptomyces hygroscopicus, naming it rapamycin after the island's native name, Rapa Nui. Originally studied as an antifungal, rapamycin became a revolutionary immunosuppressant and mTOR pathway regulator.
Later Research and Space Medicine
Beyond his work on Easter Island, Skoryna was a pioneer in the study of strontium. He investigated the effects of radioactive strontium on the body and later advocated for the use of stable strontium in treating osteoporosis and bone metastasis.
His expertise in bone metabolism led to collaborations with NASA, where he researched the effects of weightlessness on the skeletal system of astronauts.
Honors and awards
National Honors
Medalist in Surgery, Royal College of Physicians and Surgeons of Canada (1957)- Auguste Rodin Award, Canada Research and Development Corporation (1968)
Outstanding Achievement Award, City of Montreal (First recipient)
Foreign Honors
Order of Bernardo O'Higgins, Government of Chile
Cross of Merit, Republic of Poland
References
- ↑ "Stanley Constantine Skoryna (1920-2003) - Find a..." www.findagrave.com. Retrieved 2026-01-18.
- ↑ Duffin, Jacalyn (2019). Stanley's dream: the Medical Expedition to Easter Island. Carleton Library series. Montreal ; Kingston ; London ; Chicago: McGill-Queen's University Press. ISBN 978-0-7735-5710-9. Search this book on
- ↑ Stipe, David (May 27, 2012). "A New Path to Longevity". Archived from the original on Jan 18, 2026. Unknown parameter
|url-status=ignored (help)
This article "Stanley Skoryna" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Stanley Skoryna. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
